Farms.com Home   News

Rotation Key To Canola Disease Prevention


What to consider for canola and tight rotations was the topic for one of the presentations at St. Jean Farm Days on Jan. 5.

Ingrid Kristjanson, farm production advisor for the Red River GO office in Morris, told producers that last year, Manitoba seeded 3.3 million acres of canola, the highest ever acreage. But only 2.9 million of those were harvested acres.

She said this was because in the early season, many crops were too wet for too long, and 15 per cent of seeded acres were lost due to drowning.

Another production issue last year was sclerotinia, and many producers had to apply in-crop fungicides.

"Some canola grain shipments in producer cars were downgraded to #2 due to high sclerotinia presence," she said.

Blackleg lesions were also an issue.

Kristjanson said there are several things to consider when it comes to disease control in canola.

"In our cropping area, it's the heavy clay soils, and the high humidity."

She said Manitoba has the ability to target higher yields, but they're also at risk for disease organisms. Unfortunately, excellent conditions for crop production also equal excellent conditions for disease development, she said.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.